$LDOS

Leidos (LDOS) Increases Despite Market Slip: Here's What You Need to Know

Leidos (LDOS) closed at $129.55, up 1.1% from the previous day, outperforming major indices. The company's shares have fallen 8.72% over the last month. Analysts expect Q2 EPS of $3.12 and revenue of $4.72B, up 2.3% and 5.52% YoY, respectively. LDOS has a Zacks Rank of #3 (Hold) and trades at a Forward P/E of 10.35, below its industry average.

Original reporting
Published Sep 10, 2026, 9:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 4:58 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$LDOS
Neutral
medium confidence
Mentioned
$LDOS
Relevance
4/10
AlphAI data visualization · based on finance.yahoo.com
Decision brief

The 30-second read

$LDOSNeutralLow
01

Why it matters

The article provides a recap of analyst estimates and a small price move, offering little new trading impetus.

02

Market read

Limited relevance; primarily a price‑movement note without fresh corporate or macro data.

03

What to watch

Potential upcoming contract announcements or earnings could change the narrative, but none are disclosed here.

Relevance 4/10Novelty 2/10Timing: after market close

Background

Leidos reported a 1.1% gain in the latest session while broader indices fell; analysts have modestly raised EPS and revenue forecasts.

Company-level read

Ticker impact

$LDOSNeutralMedium confidence
Context

Leidos shares rose 1.1% to $129.55 despite broader market declines, with analysts highlighting upward EPS and revenue estimates.

Expected impact

Limited upside; price may hover near current levels unless fresh earnings or guidance are released.

Evidence & confidence

The article recaps analyst forecasts already public and a small intraday move, offering little actionable insight.

Market effects

Minimal; the defense and IT services sector shows no material shift beyond Leidos' own price move.

US market only; no broader regional effect noted.

Low; the story is confined to a single stock without macro implications.

Counterpoint

The price rise may be a short‑term overreaction to analyst optimism without substantive new data.

Key entities

  • Leidos

    US defense and IT services firm (ticker LDOS).

Related articles

$LDOSMedAI 9/10

Infrastructure Acquisition. Is This a Quiet AI Winner?

Leidos (NYSE: LDOS) reported Q3 revenue of $4.6B (+7% YoY) and raised 2026 guidance to $18.2B-$18.4B revenue, $12.20-$12.50 EPS. It acquired ENTRUST for $2.4B, expanding energy infrastructure. Near-term margins may dip due to acquisition costs, but long-term growth is expected from AI data center energy demand.

$AZNHighAI 8/10

AstraZeneca, Leidos, Expeditors International: CNBC ‘Final Trades’ - Expeditors International (NYSE:EXPD)

CNBC's 'Final Trades' featured picks from Jim Lebenthal (AstraZeneca, AZN), Stephen Weiss (Leidos, LDOS), Liz Thomas (Treasuries), and Joseph Terranova (Expeditors, EXPD). AZN reported regulatory approvals and strong trial data, LDOS beat Q2 estimates and raised guidance, and EXPD also exceeded Q2 expectations. Shares of AZN, LDOS, and EXPD rose 2.3%, 3.1%, and 0.5% respectively on Monday.

$LDOSMedAI 9/10

LDOS Looks 22.8% Undervalued on GF Value™

Leidos Holdings Inc (LDOS) secured an $875M contract extension from the U.S. Navy. The stock is trading at $132.83, 22.8% below its GF Value™ of $171.99, indicating undervaluation. LDOS has a GF Score™ of 78/100, reflecting strong financial health and profitability. Insiders sold $3.2M in shares over the past year.